Menu
Recruiting NCT07431359

Evaluation of Dietary Knowledge and the Habit of Using the Mediterranean Diet in Patients With Diabetes

— Observational Type 2 Diabetes

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: administration of questionnaires - Collection of Clinical Parameters - Hand Grip Test.
Who it may be relevant to
Registry conditions: Type 2 Diabetes. Basic parameters: 18 years — 80 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Italy
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Unsure about the terms? Read our patient guide →

Official title

RELATIONSHIP Between ALimentary Knowledge and Adherence to the Mediterranean Diet in Patients With DIABete Mellito Type 2 Attending an Outpatient Service (REALDIAB)

Overview

The main aim of this study is to evaluate nutritional knowledge and adherence to the Mediterranean diet through the administration of questionnaires in patients with type 2 Diabetes Mellitus belonging to Outpatient Diabetology Service of the Hospital.

Interventions

  • Other administration of questionnaires - Collection of Clinical Parameters - Hand Grip Test
    The acquisition of personal and clinical information and the data obtained from the questionnaires will be carried out in conjunction with the usual control visits planned as part of normal clinical practice

Primary outcome measures

  • Average Nutritional Knowledge Score (NK) [Time frame: through study completion, an average of 1 year]
  • Mediterranean Diet Adherence (AMD) value [Time frame: through study completion, an average of 1 year]
Secondary outcome measures (4)
  • Hand Grip test [Time frame: through study completion, an average of 1 year]
  • fasting blood glucose (mg/dL) [Time frame: through study completion, an average of 1 year]
  • glycated haemoglobin (mmol/mol) [Time frame: through study completion, an average of 1 year]
  • lipid profile (mg/dL) [Time frame: through study completion, an average of 1 year]

Eligibility criteria

Inclusion criteria

  • T2DM in nutritional and/or pharmacological euglycemic treatment (metformin, gliptins, gliflozines, incretin mimetics, pioglitazone)
  • Signing of informed consent

Exclusion criteria

  • Patient with Diabetes Mellitus type 1
  • Patients with insulin T2DM treated

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Observational model
Case-only

Study locations

Italy · 1 center
  • Ospedale P. Pederzoli Casa di Cura Privata S.p.A. — Peschiera del Garda

Identifiers

NCT: NCT07431359 · 599CET

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗